We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Clinical evaluation demonstrates utility of composite metabolic biomarkers in CKM syndrome, indicating improved cardiovascular risk prediction.
No takes yet. Share an insight, caveat, or question.
Khanna et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: